The Plaintiffs' action stems from two complaints: The Exchange Act Complaint and The Burke Action Complaint. The Exchange Act Complaint generally alleges that various false and misleading statements were made with respect to Summit's business affairs, revenues, obligations and prospects. In particular, the Exchange Act Complaint alleges that Summit pre-sold its Excimer laser prior to receiving approval from the Food and Drug Administration and that Summit misled its investors with regard to its pre-selling of this laser. The Burke Action Complaint alleges generally that the Registration Statement in connection with Summit's October 1995 Secondary Offering contained false and misleading statements and material omissions.

All persons or entities who purchased or otherwise acquired Summit Technology, Inc. common stock or call options or sold Summit put options during the period from March 31, 1995 through and including July 3, 1996 or who purchased Summit common stock issued in connection with Summit's October 1995 Secondary Offering of Summit Stock are included in the Class.

Please select from the following:
•Notice
•Proof of Claim